Cargando…

Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer

BACKGROUND: CpG islands (CGIs) are interspersed DNA sequences that have unusually high CpG ratios and GC contents. CGIs are typically located in the promoter of protein-coding genes. They normally lack DNA methylation but become hypermethylated and induce repression of associated genes in cancer. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Min Gyun, Kim, Jeong Yeon, Choi, Jung Kyoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989897/
https://www.ncbi.nlm.nih.gov/pubmed/27534853
http://dx.doi.org/10.1186/s12920-016-0198-1
_version_ 1782448623957573632
author Bae, Min Gyun
Kim, Jeong Yeon
Choi, Jung Kyoon
author_facet Bae, Min Gyun
Kim, Jeong Yeon
Choi, Jung Kyoon
author_sort Bae, Min Gyun
collection PubMed
description BACKGROUND: CpG islands (CGIs) are interspersed DNA sequences that have unusually high CpG ratios and GC contents. CGIs are typically located in the promoter of protein-coding genes. They normally lack DNA methylation but become hypermethylated and induce repression of associated genes in cancer. However, the biological functions of non-promoter CGIs (orphan CGIs) largely remain unclear. RESULTS: Here, we identify orphan CGIs that do not map to the promoter of any protein-coding or non-coding transcripts but possess chromatin and transcriptional marks that reflect enhancer activity (termed eCGIs). They exhibit three-dimensional chromatin looping toward multiple target genes with high affinity. Intriguingly, transcription regulators were frequently associated with such CGI-containing enhancers. Remarkably, our analyses in cell lines and clinical tissues showed that eCGIs have more dynamic DNA methylation changes in cancer relative to promoter CGIs. The observed eCGI hypermethylation was accompanied by a loss of enhancer marks and transcriptional inactivation of the target genes. CONCLUSION: Our results suggest that eCGIs may constitute a distinct class of enhancers and perform a more instrumental role in tumorigenesis than typical CGIs in gene promoters. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12920-016-0198-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4989897
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49898972016-08-30 Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer Bae, Min Gyun Kim, Jeong Yeon Choi, Jung Kyoon BMC Med Genomics Research BACKGROUND: CpG islands (CGIs) are interspersed DNA sequences that have unusually high CpG ratios and GC contents. CGIs are typically located in the promoter of protein-coding genes. They normally lack DNA methylation but become hypermethylated and induce repression of associated genes in cancer. However, the biological functions of non-promoter CGIs (orphan CGIs) largely remain unclear. RESULTS: Here, we identify orphan CGIs that do not map to the promoter of any protein-coding or non-coding transcripts but possess chromatin and transcriptional marks that reflect enhancer activity (termed eCGIs). They exhibit three-dimensional chromatin looping toward multiple target genes with high affinity. Intriguingly, transcription regulators were frequently associated with such CGI-containing enhancers. Remarkably, our analyses in cell lines and clinical tissues showed that eCGIs have more dynamic DNA methylation changes in cancer relative to promoter CGIs. The observed eCGI hypermethylation was accompanied by a loss of enhancer marks and transcriptional inactivation of the target genes. CONCLUSION: Our results suggest that eCGIs may constitute a distinct class of enhancers and perform a more instrumental role in tumorigenesis than typical CGIs in gene promoters. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12920-016-0198-1) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-12 /pmc/articles/PMC4989897/ /pubmed/27534853 http://dx.doi.org/10.1186/s12920-016-0198-1 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Bae, Min Gyun
Kim, Jeong Yeon
Choi, Jung Kyoon
Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer
title Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer
title_full Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer
title_fullStr Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer
title_full_unstemmed Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer
title_short Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer
title_sort frequent hypermethylation of orphan cpg islands with enhancer activity in cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989897/
https://www.ncbi.nlm.nih.gov/pubmed/27534853
http://dx.doi.org/10.1186/s12920-016-0198-1
work_keys_str_mv AT baemingyun frequenthypermethylationoforphancpgislandswithenhanceractivityincancer
AT kimjeongyeon frequenthypermethylationoforphancpgislandswithenhanceractivityincancer
AT choijungkyoon frequenthypermethylationoforphancpgislandswithenhanceractivityincancer